The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Bacterial modulation of host glycosylation - in infection, biotechnology, and therapy

Author

  • Jonathan Sjögren

Summary, in English

A majority of the proteins of the immune system are glycosylated and the glycans of IgG

are essential for its functionality. Bacteria display enzymes that modulate the glycans of

the immune system to weaken the host defense and favor bacterial survival. In this thesis

we aimed at exploring bacterial modulation of host glycosylation in infection and to

evaluate the usefulness of bacterial enzymes in biotechnology and for therapeutic use.

The role of IgG endoglycosidase EndoS in streptococcal virulence was evaluated in a

murine model of invasive infection and we found significant contribution when

heterologously expressed. We also discovered and characterized EndoS2, a novel

enzyme specific and conserved in serotype M49 of streptococci, with enzymatic activity

on the glycans of IgG and α1-acid glycoprotein. Enterococcal pathogenesis was studied,

and we found that the endoglycosidase EndoE cleaved glycans of lactoferrin to reduce

the antibacterial functions and to support bacterial growth. A glycoform specificity

difference between EndoS and EndoS2 was observed, and we suggested a method for

quantification of high-mannose glycans on therapeutic antibodies, a key quality attribute.

Finally, we explored the importance of Fc glycosylation of IgE and showed that EndoS

cleaved glycans of this immunoglobulin causing a reduction of the immune cell activation

in vivo, a potential new therapeutic strategy for severe IgE mediated allergies.

In this thesis we demonstrate that glycans are an integral part of the immune system, and

that the study of bacterial effectors of glycosylation paves the way for a deeper

understanding of infections, for novel tools supporting the biotech arena, and for new

therapeutic strategies.

Publishing year

2015

Language

English

Publication/Series

Lund University Faculty of Medicine Doctoral Dissertation Series

Volume

2015:21

Document type

Dissertation

Publisher

Division of Infection Medicine

Topic

  • Infectious Medicine

Keywords

  • IgG
  • endoglycosidase
  • Streptococcus pyogenes
  • glycosylation
  • EndoS

Status

Published

ISBN/ISSN/Other

  • ISSN: 1652-8220
  • ISBN: 978-91-7619-100-2

Defence date

13 March 2015

Defence time

09:00

Defence place

Belfragesalen, BMC D15, Klinikgatan 32, Lund

Opponent

  • Dennis Burton (Professor)